Teva, AbbVie may pay billions to settle opioid lawsuits
Teva's Adderall Shortage Seen Continuing Into March (TEVA) - Bloomberg
Teva Pharmaceuticals CEO steps down as shares continue descent - BNN Bloomberg
Teva Is Facing Adderall Supply Disruptions as Demand for ADHD Drug Soars - Bloomberg
Teva's Adderall Shortage Expected to Continue Into March, FDA Says - BNN Bloomberg
Teva flags supply constraints to ADHD drug Adderall as demand rises (NYSE: TEVA) | Seeking Alpha
Teva's CEO Was $2.8 Billion Down on His Second Day on the Job - Bloomberg
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva Pharmaceuticals Sued by U.S. Over Medicare Kickback Claims - BNN Bloomberg
Teva to Sell Assets Such as Women's Health Unit to Cut Debt - Bloomberg
The Pharma Job From Hell: Low Salary to Fix Sinking Giant Teva - Bloomberg
Buffett's Berkshire Takes Activision Blizzard Stake, Exits Teva - BNN Bloomberg
How Uggs, Hoka, and Tevas Helped Build Deckers' $2.5 Billion Ugly-Shoe Empire - Bloomberg
Teva Pharma's Short Sellers Double Down as Legal Woes Drag On - Bloomberg
Teva Is Facing Adderall Supply Disruptions as Demand for ADHD Drug Soars - BNN Bloomberg
Teva to Cut Up to 25% of Israel Workforce, Calcalist Says - Bloomberg
Teva Analysts Say Migraine Drug Approval Gives Needed Relief - Bloomberg
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg
The Pharma Job From Hell: Low Salary to Fix Sinking Giant Teva - Bloomberg
Teva CEO Resigns; Dividend Cut Should Be Next - Bloomberg
Zantac Cancer Case in US Settles for $500,000 (PRGO, TEVA) - Bloomberg
Teva Considers 10,000 Job Cuts - Bloomberg
